An experienced management executive and Registered Investment Advisor, Matt Eitner has nearly two decades of experience in the financial industry. Matt Eitner serves as the CEO of New York based Laidlaw & Company, where he leverages his considerable expertise in the healthcare sector.
A full service investment and brokerage firm, Laidlaw & Company provides investment advice and services to institutional investors and high net worth individuals. The firm also offers strategic incubation and acceleration services to select startup companies.
Emerging firms benefit from monetary investment in addition to Laidlaw’s capital market expertise. To date, these companies have included:
- Actinium Pharmaceuticals - a biopharmaceutical company that develops proprietary cancer treatment therapies for patients with no other treatment options
- Amesite - an artificial intelligence firm that provides cloud-based software solutions for online learning at institutions of higher education
- Aspen Group - an online university that provides affordable and high quality learning solutions for students
- Hoth Therapeutics - a biopharmaceutical firm driving the proprietary BioLexa drug compound platform to treat eczema
- Relmada Therapeutics - a pharmaceutical firm that develops oral treatments for depression, CNS, and ophthalmological disorders
